Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
No open-market purchases or sales by Passage BIO, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Passage BIO, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 30 | 1 | 35 | +6 |
| Shares | 1.58M | 126.6K | 1.78M | +329.3K (+22.7%) |
| Value | $18.6M | $1.49M | $13.8M | −$3.29M (−19.2%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Passage BIO, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 113,964 | $894.6K | 0.00% |
| Ikarian Capital, LLC | 68,124 | $534.8K | 0.08% |
| Verdad Advisers, LP | 22,128 | $173.7K | 0.20% |
| Diadema Partners LP | 19,530 | $153.3K | 0.06% |
| Boothbay Fund Management, LLC | 18,871 | $148.1K | 0.00% |
| Vanguard Fiduciary Trust Co | 17,049 | $133.8K | 0.00% |
| XTX Topco Ltd | 12,627 | $99.1K | 0.00% |
| Persistent Asset Partners Ltd | 4,955 | $38.9K | 0.02% |
| Vanguard Global Advisers, LLC | 638 | $5.01K | 0.00% |
| Tower Research Capital LLC (TRC) | 502 | $3.94K | 0.00% |
| Wells Fargo & Company | 115 | $903 | 0.00% |
| Royal Bank of Canada | 2 | $0 | 0.00% |
Sold out (6)
Institutions that held Passage BIO, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Citadel Advisors LLC | 17,660 | $208.4K |
| Northern Trust Corp | 14,217 | $167.8K |
| Quadrature Capital Ltd | 12,578 | $148.4K |
| Squarepoint Ops LLC | 10,799 | $127.4K |
| Nano Cap New Millennium Growth Fund L P | 10,000 | $118.0K |
| Bank of America Corp | 28 | $331 |
Not filed for Q1 2026 yet (1)
Institutions that held Passage BIO, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 126,645 | $1.49M |